63 related articles for article (PubMed ID: 18380278)
1. 3D conformal radiotherapy and cisplatin for recurrent malignant glioma.
VanderSpek L; Fisher B; Bauman G; Macdonald D
Can J Neurol Sci; 2008 Mar; 35(1):57-64. PubMed ID: 18380278
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas.
Gutin PH; Iwamoto FM; Beal K; Mohile NA; Karimi S; Hou BL; Lymberis S; Yamada Y; Chang J; Abrey LE
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):156-63. PubMed ID: 19167838
[TBL] [Abstract][Full Text] [Related]
3. Re-irradiation of recurrent gliomas: pooled analysis and validation of an established prognostic score-report of the Radiation Oncology Group (ROG) of the German Cancer Consortium (DKTK).
Combs SE; Niyazi M; Adeberg S; Bougatf N; Kaul D; Fleischmann DF; Gruen A; Fokas E; Rödel CM; Eckert F; Paulsen F; Oehlke O; Grosu AL; Seidlitz A; Lattermann A; Krause M; Baumann M; Guberina M; Stuschke M; Budach V; Belka C; Debus J; Kessel KA
Cancer Med; 2018 May; 7(5):1742-1749. PubMed ID: 29573214
[TBL] [Abstract][Full Text] [Related]
4. Phase I study of terameprocol in patients with recurrent high-grade glioma.
Grossman SA; Ye X; Peereboom D; Rosenfeld MR; Mikkelsen T; Supko JG; Desideri S;
Neuro Oncol; 2012 Apr; 14(4):511-7. PubMed ID: 22323663
[TBL] [Abstract][Full Text] [Related]
5. Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma.
Vordermark D; Kölbl O; Ruprecht K; Vince GH; Bratengeier K; Flentje M
BMC Cancer; 2005 May; 5():55. PubMed ID: 15924621
[TBL] [Abstract][Full Text] [Related]
6. Focused ultrasound combined with radiotherapy for malignant brain tumor: a preclinical and clinical study.
Chen KT; Huang CY; Pai PC; Yang WC; Tseng CK; Tsai HC; Li JC; Chuang CC; Hsu PW; Lee CC; Toh CH; Liu HL; Wei KC
J Neurooncol; 2023 Dec; 165(3):535-545. PubMed ID: 38060066
[TBL] [Abstract][Full Text] [Related]
7. A pilot study: 131I-antitenascin monoclonal antibody 81c6 to deliver a 44-Gy resection cavity boost.
Reardon DA; Zalutsky MR; Akabani G; Coleman RE; Friedman AH; Herndon JE; McLendon RE; Pegram CN; Quinn JA; Rich JN; Vredenburgh JJ; Desjardins A; Guruangan S; Boulton S; Raynor RH; Dowell JM; Wong TZ; Zhao XG; Friedman HS; Bigner DD
Neuro Oncol; 2008 Apr; 10(2):182-9. PubMed ID: 18287339
[TBL] [Abstract][Full Text] [Related]
8. Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report.
Pollack IF; Jakacki RI; Blaney SM; Hancock ML; Kieran MW; Phillips P; Kun LE; Friedman H; Packer R; Banerjee A; Geyer JR; Goldman S; Poussaint TY; Krasin MJ; Wang Y; Hayes M; Murgo A; Weiner S; Boyett JM
Neuro Oncol; 2007 Apr; 9(2):145-60. PubMed ID: 17293590
[TBL] [Abstract][Full Text] [Related]
9. Validation of Combs prognostic scoring system in Indian recurrent glioma patients treated with re-radiation.
Dutta D; Jose M; Kalavagunta S; Sasidharan A; Nair H; Edappattu AH
Radiat Oncol J; 2024 Mar; 42(1):32-42. PubMed ID: 38549382
[TBL] [Abstract][Full Text] [Related]
10. Suramin and radiotherapy in newly diagnosed glioblastoma: phase 2 NABTT CNS Consortium study.
Laterra JJ; Grossman SA; Carson KA; Lesser GJ; Hochberg FH; Gilbert MR;
Neuro Oncol; 2004 Jan; 6(1):15-20. PubMed ID: 14769135
[TBL] [Abstract][Full Text] [Related]
11. Prospective evaluation of local control and late effects of conformal radiation therapy in children, adolescents, and young adults with high-grade glioma.
Vern-Gross TZ; Schreiber JE; Broniscer A; Wu S; Xiong X; Merchant TE
Neuro Oncol; 2014 Dec; 16(12):1652-60. PubMed ID: 24908655
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of temozolomide and reirradiation using conformal 3D-radiotherapy in recurrent brain gliomas.
Osman MA
Ann Transl Med; 2014 May; 2(5):44. PubMed ID: 25333019
[TBL] [Abstract][Full Text] [Related]
13. Temozolomide and Reirradiation in Recurrent Grade II Brain Glioma.
Osman MA
World J Oncol; 2014 Jun; 5(3):118-125. PubMed ID: 29147389
[TBL] [Abstract][Full Text] [Related]
14. Pulsed low-dose rate radiotherapy for recurrent bone sarcomas: case reports and brief review.
Wong RX; Master Z; Pang E; Yang V; Looi WS
Radiat Oncol J; 2024 Mar; 42(1):88-94. PubMed ID: 38549388
[TBL] [Abstract][Full Text] [Related]
15. Palliative Benefits of the Multimodality Approach in the Re-treatment of Recurrent Malignant Glioma: Two Case Reports.
Tr A; Mg J; S N
Indian J Palliat Care; 2009 Jul; 15(2):159-61. PubMed ID: 20668597
[TBL] [Abstract][Full Text] [Related]
16. Research progress on radiotherapy technology and dose fraction scheme for advanced gliomas.
Zhang Y; Wang J
Transl Cancer Res; 2020 Dec; 9(12):7642-7651. PubMed ID: 35117363
[TBL] [Abstract][Full Text] [Related]
17. NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma.
Tsien CI; Pugh SL; Dicker AP; Raizer JJ; Matuszak MM; Lallana EC; Huang J; Algan O; Deb N; Portelance L; Villano JL; Hamm JT; Oh KS; Ali AN; Kim MM; Lindhorst SM; Mehta MP
J Clin Oncol; 2023 Feb; 41(6):1285-1295. PubMed ID: 36260832
[TBL] [Abstract][Full Text] [Related]
18. Modern reirradiation for recurrent gliomas can safely delay tumor progression.
Youland RS; Lee JY; Kreofsky CR; Brown PD; Uhm JH; Laack NN
Neurooncol Pract; 2018 Mar; 5(1):46-55. PubMed ID: 31385961
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of salvage stereotactic radiotherapy for recurrent glioma: impact of tumor morphology and method of target delineation on local control.
Ogura K; Mizowaki T; Arakawa Y; Sakanaka K; Miyamoto S; Hiraoka M
Cancer Med; 2013 Dec; 2(6):942-9. PubMed ID: 24403268
[TBL] [Abstract][Full Text] [Related]
20. Interaction of brain fatty acid-binding protein with the polyunsaturated fatty acid environment as a potential determinant of poor prognosis in malignant glioma.
Elsherbiny ME; Emara M; Godbout R
Prog Lipid Res; 2013 Oct; 52(4):562-70. PubMed ID: 23981365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
